InfuSystems Holdings Inc (INFU)
Official siteHEALTHCARE • MEDICAL INSTRUMENTS & SUPPLIES • AMEX
Market Cap: $294.89M
Last updated: Nov 17, 2026 at 11:05 AM ET
InfuSystems Holdings Inc (INFU) Financials: Revenue, Profit and Cash Flow
InfuSystems Holdings reported revenue of $143.44M for the fiscal year ended Dec 31, 2025, up 6.4% from the year before. That year, net income was $6.63M with a net margin of 4.6%, operating cash flow was $24.41M and free cash flow was $23.85M. The quarter ended Sep 30, 2026 had revenue of $37.59M and net income of $3.16M.
Revenue and Margins
The operating margin was 8.3% in the fiscal year ended Dec 2025. Over the 9 years to Dec 2025, revenue grew from $70.50M, a compound annual rate of 8.2%.
| Fiscal year | Revenue | Growth | Gross margin | Operating margin | Net margin |
|---|---|---|---|---|---|
| Dec 2025 | $143.44M | +6.4% | 56.0% | 8.3% | 4.6% |
| Dec 2024 | $134.86M | +7.2% | 52.2% | 5.1% | 1.7% |
| Dec 2023 | $125.78M | +14.4% | 50.2% | 3.2% | 0.7% |
| Dec 2022 | $109.91M | +7.4% | 55.1% | 1.5% | 0.0% |
| Dec 2021 | $102.38M | +5.1% | 57.2% | 2.8% | 1.4% |
| Dec 2020 | $97.39M | +20.1% | 59.5% | 9.1% | 17.8% |
| Dec 2019 | $81.11M | +20.8% | 57.8% | 4.3% | 1.7% |
| Dec 2018 | $67.14M | -5.5% | 58.9% | 0.6% | -1.6% |
| Dec 2017 | $71.08M | +0.8% | 61.0% | -5.4% | -29.1% |
| Dec 2016 | $70.50M | N/A | 55.5% | 1.4% | -0.3% |
Income Statement
In the fiscal year ended Dec 2025, net income rose 182.1% from the year before. In the quarter ended Sep 2026, net income rose 39.8% from the same quarter a year earlier.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $143.44M | $134.86M | $125.78M | $109.91M | $102.38M | $97.39M | $81.11M | $67.14M | $71.08M | $70.50M |
| Cost of revenue | $63.14M | $64.46M | $62.68M | $49.35M | $43.85M | $39.42M | $34.23M | $27.57M | $27.72M | $31.39M |
| Gross profit | $80.30M | $70.40M | $63.11M | $60.56M | $58.54M | $57.97M | $46.88M | $39.57M | $43.36M | $39.11M |
| Operating income | $11.92M | $6.89M | $4.09M | $1.65M | $2.82M | $8.83M | $3.52M | $415.00K | -$3.81M | $974.00K |
| Net income | $6.63M | $2.35M | $872.00K | $18.00K | $1.42M | $17.33M | $1.36M | -$1.09M | -$20.71M | -$222.00K |
| EBITDA | $25.30M | $19.41M | $16.65M | $14.96M | $17.41M | $22.84M | $15.81M | $11.72M | $8.63M | $11.76M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $37.59M | $36.93M | $33.68M | $36.23M | $36.49M | $36.00M | $34.72M | $33.85M | $35.32M | $33.70M | $32.00M | $31.77M |
| Gross profit | $21.73M | $21.41M | $19.68M | $20.43M | $20.82M | $19.87M | $19.17M | $18.22M | $19.05M | $16.67M | $16.47M | $16.71M |
| Operating income | $4.75M | $4.15M | $1.59M | $3.71M | $3.81M | $3.78M | $618.00K | $2.62M | $3.27M | $1.85M | -$845.00K | $1.25M |
| Net income | $3.16M | $3.23M | $1.02M | $2.04M | $2.26M | $2.60M | -$267.00K | $933.00K | $1.81M | $717.00K | -$1.11M | $72.00K |
Balance Sheet
As of Dec 2025, long-term debt of $19.63M exceeded cash and equivalents by $16.44M.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $100.56M | $103.61M | $102.92M | $99.39M | $97.59M | $96.99M | $79.22M | $64.07M | $68.88M | $96.34M |
| Current assets | $36.34M | $32.16M | $30.62M | $24.78M | $22.07M | $29.77M | $19.30M | $17.54M | $17.67M | $20.77M |
| Cash and equivalents | $3.19M | $527.00K | $231.00K | $165.00K | $186.00K | $9.65M | $2.65M | $4.32M | $3.47M | $3.40M |
| Total liabilities | $43.23M | $46.09M | $50.61M | $51.38M | $49.31M | $56.24M | $56.89M | $43.63M | $37.93M | $45.66M |
| Short-term debt | N/A | N/A | $1.47M | $931.00K | $349.00K | $9.42M | $8.08M | $4.90M | $3.54M | $8.25M |
| Long-term debt | $19.63M | $23.86M | $29.10M | $33.16M | $32.75M | $29.38M | $30.30M | $28.84M | $25.35M | $26.58M |
| Shareholder equity | $57.33M | $57.53M | $52.30M | $48.00M | $48.27M | $40.75M | $22.33M | $20.44M | $30.95M | $50.69M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $104.52M | $97.70M | $98.66M | $100.56M | $98.88M | $100.85M | $104.28M | $103.61M | $105.30M | $108.53M | $104.85M | $102.92M |
| Total liabilities | $40.37M | $38.55M | $39.91M | $43.23M | $43.41M | $46.31M | $49.13M | $46.09M | $49.79M | $55.04M | $52.57M | $50.61M |
| Cash and equivalents | $9.11M | $964.00K | $2.11M | $3.19M | $955.00K | $720.00K | $1.51M | $527.00K | $380.00K | $146.00K | $822.00K | $231.00K |
| Shareholder equity | $64.15M | $59.15M | $58.75M | $57.33M | $55.47M | $54.53M | $55.15M | $57.53M | $55.51M | $53.49M | $52.28M | $52.30M |
Cash Flow
In the fiscal year ended Dec 2025, free cash flow was 97.7% of operating cash flow. Share repurchases came to 41.4% of it.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $24.41M | $20.46M | $11.22M | $17.52M | $18.32M | $20.28M | $13.88M | $11.39M | $7.72M | $7.91M |
| Capital expenditures | $560.00K | $1.09M | $1.02M | $982.00K | $980.00K | $1.09M | $2.93M | $281.00K | $2.76M | $5.27M |
| Free cash flow | $23.85M | $19.37M | $10.20M | $16.54M | $17.34M | $19.19M | $10.95M | $11.11M | $4.96M | $2.64M |
| Dividends paid | N/A | N/A | $4.27M | $1.35M | $1.12M | $190.00K | $252.00K | N/A | $0 | $0 |
| Share repurchases | $9.87M | $1.18M | $153.00K | $5.46M | $560.00K | $0 | $0 | $10.39M | $0 | N/A |
| Investing cash flow | -$6.79M | -$13.24M | -$6.73M | -$11.48M | -$21.32M | -$12.16M | -$19.64M | -$4.98M | $918.00K | -$5.34M |
| Financing cash flow | -$14.96M | -$6.92M | -$4.42M | -$6.06M | -$6.46M | -$1.12M | $4.10M | -$5.56M | -$8.56M | $15.00K |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $10.34M | $6.78M | $970.00K | $7.13M | $8.49M | $7.01M | $1.78M | $7.93M | $9.84M | $2.31M | $377.00K | $4.66M |
| Capital expenditures | $73.00K | $91.00K | $157.00K | $133.00K | $79.00K | $217.00K | $131.00K | $530.00K | $43.00K | $337.00K | $182.00K | $408.00K |
| Free cash flow | $10.27M | $6.69M | $813.00K | $6.99M | $8.41M | $6.79M | $1.65M | $7.40M | $9.80M | $1.97M | $195.00K | $4.25M |
Frequently Asked Questions About INFU
What is InfuSystems Holdings' annual revenue?
InfuSystems Holdings reported revenue of $143.44M for the fiscal year ended Dec 31, 2025.
How fast is InfuSystems Holdings' revenue growing?
Revenue was up 6.4% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was 9.3%.
Is InfuSystems Holdings profitable?
Yes. InfuSystems Holdings reported net income of $6.63M for the fiscal year ended Dec 31, 2025, with a net margin of 4.6%.
How much free cash flow does INFU generate?
For the fiscal year ended Dec 31, 2025, operating cash flow of $24.41M minus capital expenditures of $560.00K produced free cash flow of $23.85M.
How much debt does InfuSystems Holdings have?
The balance sheet dated Dec 31, 2025 reported long-term debt of $19.63M and cash and equivalents of $3.19M.
INFU pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors